Provided by Tiger Trade Technology Pte. Ltd.

Mersana Therapeutics Inc.

27.52
+0.09000.33%
Post-market: 27.44-0.0758-0.28%16:53 EST
Volume:30.01K
Turnover:826.51K
Market Cap:137.57M
PE:-1.95
High:27.69
Open:27.50
Low:27.36
Close:27.43
52wk High:70.73
52wk Low:5.21
Shares:5.00M
Float Shares:3.75M
Volume Ratio:0.49
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0861
EPS(LYR):-14.1163
ROE:-505.14%
ROA:-36.27%
PB:-2.31
PE(LYR):-1.95

Loading ...

Mersana Therapeutics Q3 EPS USD -1.51

Reuters
·
Nov 20

Mersana Therapeutics Faces High Stakes with Potential Day One Biopharmaceuticals Merger Delays

TIPRANKS
·
Nov 15

BUZZ-Nasdaq biotech index hits record high, set to gain nearly 5% this week

Reuters
·
Nov 15

Mersana Therapeutics reports third quarter 2025 financial results

Reuters
·
Nov 14

BRIEF-Mersana Therapeutics Q3 EPS USD -1.51

Reuters
·
Nov 14

Mersana Therapeutics Q3 Collaboration Revenue USD 11.009 Million

THOMSON REUTERS
·
Nov 14

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14

Mersana Therapeutics Inc : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Nov 14

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
Nov 14

William Blair downgrades Mersana Therapeutics (MRSN) to a Hold

TIPRANKS
·
Nov 14

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Reuters
·
Nov 14

Mersana Therapeutics Inc : Baird Raises Target Price to $29 From $8

THOMSON REUTERS
·
Nov 14

Mersana Therapeutics Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $29 From $44

THOMSON REUTERS
·
Nov 13

Mersana Therapeutics Inc : Truist Securities Cuts to Hold From Buy; Cuts Target Price to $30.75 From $36

THOMSON REUTERS
·
Nov 13

Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’

TIPRANKS
·
Nov 13

Mersana Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
Nov 13

Mersana Therapeutics Inc : Wedbush Cuts Neutral From Outperform; Raises Target Price to $27.25 From $13

THOMSON REUTERS
·
Nov 13

Day One to Buy Mersana Therapeutics for Up to $285 Million

Dow Jones
·
Nov 13

Mersana Therapeutics Shares Climb 206% Premarket After Co to Be Acquired by Day One Biopharmaceuticals

THOMSON REUTERS
·
Nov 13

Mersana Therapeutics Inc Proposed Deal for $25.00 per Share in Cash

THOMSON REUTERS
·
Nov 13